Drug Database · Clinicians

Phenylephrine + Tropicamide

Brands (4) Auromide Plus, Fenlomax-T, Sanmyd-P…Show all

Mydriatic agent (Anticholinergic/Andrenergic agonist); Anticholinergic/ adrenergic agonist PH FDA category
Fixed-dose combination.

Rx · Prescription drug4 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Uses temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure US FDA label

  • Use: INDICATIONS AND USAGE For mydriasis and cycloplegia for diagnostic procedures. US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Per ml ophthalmic solution: 5 mg/5 mg, 8 mg/50 mg
  • Ophthalmic solution: 8 mg/mL (0.8 w/v)/50 mg/mL

Registered products in the Philippines

4 products registered with the Food and Drug Administration (FDA) Philippines list Phenylephrine + Tropicamide as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products4
Philippine FDA-registered products for Phenylephrine + Tropicamide
Package insert
Auromide PlusTropicamide + Phenylephrine Hydrochloride
8 mg/mL (0.8 w/v)/ 50 mg/mL (5% w/v) Ophthalmic SolutionWhite Opaque LDPE Dropper Bottle x 5 mL (Box of 1's)
Rx
AurolabIndia
Brady Pharma Inc.
DRP-4021
Jun 4, 2028
Fenlomax-TTropicamide + Phenylephrine hydrochloride
8mg/50mg per mL (0.8% w/v / 5.0% w/v) Ophthalmic Solution (Eye Drops)White LDPE Bottle with Screw Cap x 5mL (Box of 1’s)
Rx
Makers Laboratories LtdIndia
Blue Global (FZE)
DRP-18136
May 13, 2031
Sanmyd-PTropicamide + Phenylephrine Hydrochloride
5 mg/5 mg per mL (0.5%/ 0.5% w/v) Ophthalmic Solution (Eye Drops)PP Transparent bluish plastic bottle with PE white tip and cap x 10 mL (net content) (Box of 1's)
Rx
Santen Pharmaceutical Co., Ltd. (Shiga Plant)Japan
Importer: Santen Philippines Inc.
DR-XY25408
Mar 23, 2027
TropisightTropicamide + Phenylephrine Hydrochloride
8 mg/50 mg per mL (0.8% w/v / 5% w/v) Ophthalmic SolutionLDPE bottle x 5 mL with white nozzle and cap (Box of 1's)
Rx
Makcur Laboratories LimitedIndia
Ensight Pharmaceuticals Inc.Trader: Entod Pharmaceuticals Ltd.
DR-XY49588
Nov 17, 2031

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Tropicamide + Phenylephrine Hydrochloride 5 mg + 5 mg/mL, 10 mL Eye Drops₱498.75–₱532.00Reference ₱498.75per unitDPRI procurement range

Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Tropicamide + phenylephrine hydrochloride
PNF listingOphthalmic Solution: 5 mg + 5 mg/mL (eye drops) fixed dose combination, 10 mL bottle
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  3. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .